Brett P. Monia - 22 May 2023 Form 4 Insider Report for IONIS PHARMACEUTICALS INC (IONS)

Signature
By: Patrick R. O'Neil, attorney-in-fact For: Brett P. Monia
Issuer symbol
IONS
Transactions as of
22 May 2023
Net transactions value
-$197,907
Form type
4
Filing time
24 May 2023, 20:25:09 UTC
Previous filing
07 Feb 2023
Next filing
13 Jun 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IONS Common Stock Sale $92,339 -2,301 -1.6% $40.13 143,004 22 May 2023 Direct F1
transaction IONS Common Stock Sale $105,568 -2,630 -1.8% $40.14 140,374 22 May 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 16, 2022.